Self-management interventions for people with severe mental illness: systematic review and meta-analysis.

Schizophrenia bipolar affective disorders community mental health teams psychosocial interventions psychotic disorders

Journal

The British journal of psychiatry : the journal of mental science
ISSN: 1472-1465
Titre abrégé: Br J Psychiatry
Pays: England
ID NLM: 0342367

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 23 3 2019
medline: 9 4 2020
entrez: 23 3 2019
Statut: ppublish

Résumé

Self-management is intended to empower individuals in their recovery by providing the skills and confidence they need to take active steps in recognising and managing their own health problems. Evidence supports such interventions in a range of long-term physical health conditions, but a recent systematic synthesis is not available for people with severe mental health problems.AimsTo evaluate the effectiveness of self-management interventions for adults with severe mental illness (SMI). A systematic review of randomised controlled trials was conducted. A meta-analysis of symptomatic, relapse, recovery, functioning and quality of life outcomes was conducted, using RevMan. A total of 37 trials were included with 5790 participants. From the meta-analysis, self-management interventions conferred benefits in terms of reducing symptoms and length of admission, and improving functioning and quality of life both at the end of treatment and at follow-up. Overall the effect size was small to medium. The evidence for self-management interventions on readmissions was mixed. However, self-management did have a significant effect compared with control on subjective measures of recovery such as hope and empowerment at follow-up, and self-rated recovery and self-efficacy at both time points. There is evidence that the provision of self-management interventions alongside standard care improves outcomes for people with SMI. Self-management interventions should form part of the standard package of care provided to people with SMI and should be prioritised in guidelines: research on best methods of implementing such interventions in routine practice is needed.Declaration of interestsNone.

Sections du résumé

BACKGROUND
Self-management is intended to empower individuals in their recovery by providing the skills and confidence they need to take active steps in recognising and managing their own health problems. Evidence supports such interventions in a range of long-term physical health conditions, but a recent systematic synthesis is not available for people with severe mental health problems.AimsTo evaluate the effectiveness of self-management interventions for adults with severe mental illness (SMI).
METHOD
A systematic review of randomised controlled trials was conducted. A meta-analysis of symptomatic, relapse, recovery, functioning and quality of life outcomes was conducted, using RevMan.
RESULTS
A total of 37 trials were included with 5790 participants. From the meta-analysis, self-management interventions conferred benefits in terms of reducing symptoms and length of admission, and improving functioning and quality of life both at the end of treatment and at follow-up. Overall the effect size was small to medium. The evidence for self-management interventions on readmissions was mixed. However, self-management did have a significant effect compared with control on subjective measures of recovery such as hope and empowerment at follow-up, and self-rated recovery and self-efficacy at both time points.
CONCLUSION
There is evidence that the provision of self-management interventions alongside standard care improves outcomes for people with SMI. Self-management interventions should form part of the standard package of care provided to people with SMI and should be prioritised in guidelines: research on best methods of implementing such interventions in routine practice is needed.Declaration of interestsNone.

Identifiants

pubmed: 30898177
pii: S0007125019000540
doi: 10.1192/bjp.2019.54
pmc: PMC6499726
mid: EMS81994
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

260-268

Subventions

Organisme : Department of Health
ID : RP-PG-0109-10078
Pays : United Kingdom

Références

J Affect Disord. 2012 Dec 15;142(1-3):98-105
pubmed: 22858215
Contemp Clin Trials. 2012 Jul;33(4):679-88
pubmed: 22387150
Soc Psychiatry Psychiatr Epidemiol. 2006 Jun;41(6):464-9
pubmed: 16565915
Am J Psychiatry. 1992 Nov;149(11):1549-55
pubmed: 1384364
Arch Gen Psychiatry. 2003 Apr;60(4):402-7
pubmed: 12695318
Psychol Med. 2017 Sep;47(12):2081-2096
pubmed: 28374661
Psychiatr Rehabil J. 2013 Dec;36(4):243-9
pubmed: 24320832
Am J Psychiatry. 2013 Aug;170(8):852-9
pubmed: 23511717
Psychiatr Serv. 2012 Jan;63(1):54-60
pubmed: 22227760
Psychiatr Serv. 1998 Oct;49(10):1313-6
pubmed: 9779901
Schizophr Res. 2006 Oct;87(1-3):338-9
pubmed: 16844344
Psychiatr Serv. 2009 Sep;60(9):1182-9
pubmed: 19723732
Schizophr Bull. 2012 Jun;38(4):881-91
pubmed: 21402724
Bipolar Disord. 2011 Aug-Sep;13(5-6):571-7
pubmed: 22017225
Psychiatr Serv. 2006 Jul;57(7):927-36
pubmed: 16816276
Community Ment Health J. 2013 Jun;49(3):260-9
pubmed: 22167660
Lancet. 2004 Jun 19;363(9426):2063-72
pubmed: 15207959
Occup Ther Int. 2007;14(2):86-98
pubmed: 17623381
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Psychiatr Serv. 2018 May 1;69(5):562-571
pubmed: 29446335
Yonsei Med J. 2002 Oct;43(5):579-89
pubmed: 12402370
J Ment Health. 2018 Feb;27(1):30-37
pubmed: 27841057
Psychiatr Serv. 2006 Jul;57(7):937-45
pubmed: 16816277
Aust N Z J Psychiatry. 2007 Nov;41(11):903-9
pubmed: 17924243
Psychiatr Serv. 2007 Nov;58(11):1461-6
pubmed: 17978257
Schizophr Res. 2007 Nov;96(1-3):232-45
pubmed: 17826034
J Affect Disord. 2014 Dec;169:21-9
pubmed: 25129531
Br J Psychiatry. 2007 Jan;190:49-56
pubmed: 17197656
J Clin Nurs. 2017 Nov;26(21-22):3471-3485
pubmed: 28032918
Community Ment Health J. 2012 Aug;48(4):420-30
pubmed: 22460927
Int J Ment Health Nurs. 2013 Jun;22(3):256-71
pubmed: 22882803
Psychiatr Serv. 2009 Dec;60(12):1629-36
pubmed: 19952153
Br J Psychiatry. 2009 Mar;194(3):260-5
pubmed: 19252157
BMC Res Notes. 2017 Nov 09;10(1):588
pubmed: 29122001
Psychiatr Rehabil J. 2013 Dec;36(4):250-7
pubmed: 24320833
Psychiatr Serv. 2009 Apr;60(4):491-7
pubmed: 19339324
Schizophr Bull. 2008 May;34(3):523-37
pubmed: 17962231
Annu Rev Clin Psychol. 2013;9:465-97
pubmed: 23330939
Psychiatr Serv. 2011 Jun;62(6):606-12
pubmed: 21632728
Br J Psychiatry. 1996 Feb;168(2):199-204
pubmed: 8837910
Shanghai Arch Psychiatry. 2014 Apr;26(2):81-7
pubmed: 25092953
Psychiatr Serv. 2013 Apr 1;64(4):376-9
pubmed: 23412024
BMJ. 1999 Jan 16;318(7177):149-53
pubmed: 9888904
Schizophr Bull. 2016 Jul;42 Suppl 1:S71-80
pubmed: 27460620
PLoS One. 2018 Apr 5;13(4):e0194027
pubmed: 29621284
Psychiatr Serv. 2012 Jun;63(6):541-7
pubmed: 22508435
Psychiatr Serv. 2002 May;53(5):545-7
pubmed: 11986501
Br J Psychiatry. 2014 Jul;205(1):52-9
pubmed: 24809397
Br J Psychiatry. 2011 Dec;199(6):445-52
pubmed: 22130746
BMJ. 2001 Jul 14;323(7304):101-5
pubmed: 11451790
Psychiatr Serv. 2002 Oct;53(10):1272-84
pubmed: 12364675
Psychiatr Serv. 2006 Jun;57(6):822-8
pubmed: 16754759
Clin Psychol Rev. 2015 Jul;39:96-112
pubmed: 26046501
Br J Psychiatry. 2014 Jan;204(1):20-9
pubmed: 24385461
Neuropsychiatr Dis Treat. 2016 Dec 07;12:3097-3110
pubmed: 27994466
Psychiatr Serv. 2014 Aug 1;65(8):1005-11
pubmed: 24733680
Cochrane Database Syst Rev. 2015 Apr 09;(4):CD010823
pubmed: 25854522
Am J Psychiatry. 2009 Nov;166(11):1244-50
pubmed: 19797436
Community Ment Health J. 2010 Aug;46(4):319-29
pubmed: 20077006
Schizophr Res. 2012 Apr;136(1-3):36-42
pubmed: 22130108

Auteurs

Melanie Lean (M)

Trainee Clinical Psychologist,Division of Psychology and Language Sciences,University College London,UK.

Miriam Fornells-Ambrojo (M)

Lecturer in Clinical Psychology,Division of Psychology and Language Sciences,University College London,UK.

Alyssa Milton (A)

Postdoctoral Research Fellow,Brain and Mind Centre,University of Sydney,Australia.

Brynmor Lloyd-Evans (B)

Senior Lecturer in Mental Health and Social Care,Division of Psychiatry,University College London,UK.

Bronwyn Harrison-Stewart (B)

Research Assistant,Centre for Outcomes Research and Effectiveness,University College London,UK.

Amina Yesufu-Udechuku (A)

Research Associate,Centre for Outcomes Research and Effectiveness,University College London,UK.

Tim Kendall (T)

National Clinical Director,Mental Health NHS England,UK.

Sonia Johnson (S)

Professor of Social and Community Psychiatry,Division of Psychiatry,University College London,UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH